AcNK-Sup003 cell injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AcNK-Sup003 cell injection, covering 2024-11-19 to 2024-11-19. Get the full timeline:
Most recent: Clinical Trial Update: An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma [EARLY_Phase 1]